Over the last two years, issues with both financial control and transparency, both of which the current Board of Directors was charged with overseeing, have obscured a skilled defense of the Adoxa and Keralac brands and an attempt to gain greater patent protection for the Bradley product portfolio.

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.